文献速递免疫规划卫生政策与健康促进

美国成人流感、更新版COVID-19及呼吸道合胞病毒疫苗接种覆盖率——2023年秋季

Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-12-22

基于全国免疫调查-成人COVID模块随机-digit拨号手机调查数据,截至2023年12月9日,≥18岁成人中42.2%报告接种流感疫苗、18.3%接种更新版2023-2024 COVID-19疫苗,≥60岁成人中17.0%接种RSV疫苗;覆盖率随人口学特征而异,约27%和41%的≥18岁成人及53%的≥60岁成人表示肯定或可能会接种或不确定是否接种相应疫苗;强有力的提供者推荐和接种提议可提高覆盖率。

要点

  • 截至2023年12月9日,≥18岁成人流感疫苗接种覆盖率为42.2%,更新版2023-2024 COVID-19疫苗为18.3%。
  • ≥60岁成人RSV疫苗接种覆盖率为17.0%。
  • 约27%和41%的≥18岁成人及53%的≥60岁成人表示肯定或可能会接种或不确定是否接种相应疫苗。

核心结论

  • 截至2023年12月9日,美国成人流感、更新版2023-2024 COVID-19和RSV疫苗接种覆盖率分别为42.2%、18.3%和17.0%(≥60岁)。
  • 覆盖率随人口学特征而异。
  • 强有力的提供者推荐和接种提议可提高流感、COVID-19和RSV疫苗接种覆盖率。

研究设计与样本

  • 数据来源于全国免疫调查-成人COVID模块,该调查是对美国≥18岁成人进行的随机-digit拨号手机调查。

主要发现

  • 截至2023年12月9日,估计42.2%的≥18岁成人报告接种流感疫苗,18.3%报告接种更新版2023-2024 COVID-19疫苗。
  • 17.0%的≥60岁成人已接种RSV疫苗。
  • 约27%和41%的≥18岁成人及53%的≥60岁成人报告肯定或可能会接种或不确定是否接种流感、COVID-19和RSV疫苗。

关键数值与推荐

  • 免疫实践咨询委员会推荐所有≥6月龄人群接种流感疫苗和COVID-19疫苗。
  • RSV疫苗推荐用于≥60岁人群(采用共享临床决策)和孕妇。

临床怎么用

  • 免疫规划和接种伙伴被鼓励使用这些数据了解其管辖范围内的接种模式和接种态度,以指导规划、实施、加强和评估接种活动。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

During the 2023-24 respiratory virus season, the Advisory Committee on Immunization Practices recommends influenza and COVID-19 vaccines for all persons aged ≥6 months, and respiratory syncytial virus (RSV) vaccine is recommended for persons aged ≥60 years (using shared clinical decision-making), and for pregnant persons. Data from the National Immunization Survey-Adult COVID Module, a random-digit-dialed cellular telephone survey of U.S. adults aged ≥18 years, are used to monitor influenza, COVID-19, and RSV vaccination coverage. By December 9, 2023, an estimated 42.2% and 18.3% of adults aged ≥18 years reported receiving an influenza and updated 2023-2024 COVID-19 vaccine, respectively; 17.0% of adults aged ≥60 years had received RSV vaccine. Coverage varied by demographic characteristics. Overall, approximately 27% and 41% of adults aged ≥18 years and 53% of adults aged ≥60 years reported that they definitely or probably will be vaccinated or were unsure whether they would be vaccinated against influenza, COVID-19, and RSV, respectively. Strong provider recommendations for and offers of vaccination could increase influenza, COVID-19, and RSV vaccination coverage. Immunization programs and vaccination partners are encouraged to use these data to understand vaccination patterns and attitudes toward vaccination in their jurisdictions to guide planning, implementation, strengthening, and evaluation of vaccination activities.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Black CL, Kriss JL, Razzaghi H, et al. Influenza, Updated COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2023. MMWR Morb Mortal Wkly Rep. 2023. PMID: 38127675. doi:10.15585/mmwr.mm7251a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。